Loading patent…
AssigneePiramal Life Sciences Limited
InventorsMuralidhara Padigaru, Somesh Sharma, Arvind Thakkar, Anandharajan Rathina Sabapathy, Sapna Hasit Parikh, Usha Ghosh
Estimating the term…
The present invention relates to nucleotide and protein sequences of epiregulin and epiregulin like proteins and nucleotides and methods employing them as a drug response marker in inflammatory conditions. The invention also provides epiregulin protein for treatment of inflammatory conditions like psoriasis and rheumatoid arthritis alone or in combination with one or more anti-inflammatory compounds.
A method for predicting the response of a patient to a drug employed in the treatment of inflammatory condition in the patient, the method comprising:
A method for monitoring drug response in patients receiving treatment for inflammatory condition, the method comprising:
A method of determining the likelihood of a subject developing inflammatory condition, the method comprising:
A method of treating a subject suffering from inflammatory condition comprising:
A method of monitoring drug response in a patient receiving treatment for inflammatory condition with anti-inflammatory compounds, the method comprising:
Dependencies are inferred from the claim text.